No free lunch—the price of double versus triple antithrombotic therapy in patients with atrial fibrillation after ACS or PCI

por Valgimigli, Marco, Gragnano, Felice
Publicado 2020

A call for action in bleeding prevention

por Gragnano, Felice, Manavifar, Negar, Valgimigli, Marco
Publicado 2019

The impact of the COVID-19 pandemic upon patients, staff, and on the future practices of percutaneous coronary intervention

por Banning, Adrian P, Sabate, Manel, Valgimigli, Marco
Publicado 2020

Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help

por Gargiulo, Giuseppe, Goette, Andreas, Vranckx, Pascal, Valgimigli, Marco
Publicado 2020

A new iteration for the single-access large-bore technique during Impella supported complex and high-risk coronary intervention: a case report

por Araco, Marco, Quagliana, Angelo, Pedrazzini, Giovanni, Valgimigli, Marco
Publicado 2021

Perspectives on the 2014 ESC/EACTS Guidelines on Myocardial Revascularization: Fifty Years of Revascularization: Where Are We and Where Are We Heading?

por Costa, Francesco, Ariotti, Sara, Valgimigli, Marco, Kolh, Philippe, Windecker, Stephan
Publicado 2015

Boosting platelet inhibition in poor responder to aspirin and clopidogrel undergoing percutaneous coronary intervention: role of tirofiban

por Campo, Gianluca, Fileti, Luca, Valgimigli, Marco, Marchesini, Jlenia, Scalone, Antonella, Ferrari, Roberto
Publicado 2010

Abciximab: a reappraisal of its use in coronary care

por Valgimigli, Marco, Campo, Gianluca, Tebaldi, Matteo, Carletti, Roberto, Arcozzi, Chiara, Ferrari, Roberto, Percoco, Gianfranco
Publicado 2008

Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEU...

por Iglesias, Juan F., Valgimigli, Marco, Carbone, Federico, Lauriers, Nathalie, Masci, Pier-Giorgio, Degrauwe, Sophie
Publicado 2022

The multiplication of loaves and fishes approach: a critic to double anti-thrombotics or to double number of ischaemic events?

por Gargiulo, Giuseppe, Cannon, Christopher P, Gibson, Charles Michael, Lopes, Renato D, Vranckx, Pascal, Valgimigli, Marco
Publicado 2020

Comparing methods for estimating patient‐specific treatment effects in individual patient data meta‐analysis

por Seo, Michael, White, Ian R., Furukawa, Toshi A., Imai, Hissei, Valgimigli, Marco, Egger, Matthias, Zwahlen, Marcel, Efthimiou, Orestis
Publicado 2020

Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis

por Goette, Andreas, Eckardt, Lars, Valgimigli, Marco, Lewalter, Thorsten, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan G., Vranckx, Pascal
Publicado 2020

Incremental Value of the CRUSADE, ACUITY, and HAS‐BLED Risk Scores for the Prediction of Hemorrhagic Events After Coronary Stent Implantation in Patients Undergoing Long or Short D...

por Costa, Francesco, Tijssen, Jan G., Ariotti, Sara, Giatti, Sara, Moscarella, Elisabetta, Guastaroba, Paolo, De Palma, Rossana, Andò, Giuseppe, Oreto, Giuseppe, Zijlstra, Felix, Valgimigli, Marco
Publicado 2015

Stent and Dual Antiplatelet Therapy Duration Comparisons in the Setting of a Multicenter Randomized Controlled Trial: Can the Operator Experience Affect the Study Results?

por Gargiulo, Giuseppe, Heg, Dik, Ferrari, Fabrizio, Percoco, Gianfranco, Campo, Gianluca, Tumscitz, Carlo, Colombo, Federico, Zuffi, Andrea, Castriota, Fausto, Cremonesi, Alberto, Windecker, Stephan, Valgimigli, Marco
Publicado 2017

Safety and efficacy of double vs. triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary interv...

por Gargiulo, Giuseppe, Cannon, Christopher P, Gibson, Charles Michael, Goette, Andreas, Lopes, Renato D, Oldgren, Jonas, Korjian, Serge, Windecker, Stephan, Esposito, Giovanni, Vranckx, Pascal, Valgimigli, Marco
Publicado 2020

Pharmacosimulation of delays and interruptions during administration of tirofiban: a systematic comparison between EU and US dosage regimens

por Heramvand, Nadia, Masyuk, Maryna, Muessig, Johanna M., Nia, Amir M., Karathanos, Athanasios, Polzin, Amin, Valgimigli, Marco, Gurbel, Paul A., Tantry, Udaya S., Kelm, Malte, Jung, Christian
Publicado 2022

Mechanical complications in patients with ST-segment elevation myocardial infarction: A single centre experience

por Lanz, Jonas, Wyss, Dörte, Räber, Lorenz, Stortecky, Stefan, Hunziker, Lukas, Blöchlinger, Stefan, Reineke, David, Englberger, Lars, Zanchin, Thomas, Valgimigli, Marco, Heg, Dik, Windecker, Stephan, Pilgrim, Thomas
Publicado 2019

Self-reported non-adherence to P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: Application of the medication non-adherence academic research consortium...

por Ueki, Yasushi, Zanchin, Thomas, Losdat, Sylvain, Karagiannis, Alexios, Otsuka, Tatsuhiko, Siontis, George C. M., Häner, Jonas, Stortecky, Stefan, Pilgrim, Thomas, Valgimigli, Marco, Windecker, Stephan, Räber, Lorenz
Publicado 2022

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

por Navarese, Eliano Pio, Andreotti, Felicita, Schulze, Volker, Kołodziejczak, Michalina, Buffon, Antonino, Brouwer, Marc, Costa, Francesco, Kowalewski, Mariusz, Parati, Gianfranco, Lip, Gregory Y H, Kelm, Malte, Valgimigli, Marco
Publicado 2015

Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI...

por Vranckx, Pascal, Valgimigli, Marco, Eckardt, Lars, Lewalter, Thorsten, Unikas, Ramunas, Marin, Francisco, Schiele, François, Laeis, Petra, Reimitz, Paul-Egbert, Smolnik, Rüdiger, Zierhut, Wolfgang, Tijssen, Jan, Goette, Andreas
Publicado 2020